Self-reported cognitive impairments and quality of life in patients with gastrointestinal stromal tumor: Results of a multinational survey.

Cancer(2022)

引用 1|浏览8
暂无评分
摘要
A majority of GIST patients report cognitive symptoms that have a negative impact on quality of life, with longer term survivors (≥5 years) tending to report more cognitive impairments. Given the success of TKI therapy to substantially increase overall survival of patients with GIST, addressing CRCI in clinical practice may improve long-term GIST survivor function and quality of life.
更多
查看译文
关键词
cancer-related cognitive impairment,gastrointestinal stromal tumor (GIST),neurocognitive outcomes,quality of life,tyrosine kinase inhibitor therapy
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要